Physician profile
Dean A Behner
NPI 1386629590
$1,115.48
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $349 · 2020: $242 · 2021: $407 · 2023: $117.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $117.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $117.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $164.54 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $156.67 | 2019-2021 | |
| Lilly USA, LLC | $140.84 | 2020-2021 | |
| Pfizer INC. | $119.39 | 2019-2021 | |
| Amgen INC. | $117.00 | 2023 | Repatha |
| Indivior INC. | $105.41 | 2019-2020 | |
| Esperion Therapeutics, INC. | $44.15 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $42.52 | 2019 | |
| Allergan, INC. | $42.37 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $37.36 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $29.58 | 2020 | |
| Abbott Laboratories | $24.02 | 2021 | |
| Glaxosmithkline, LLC. | $18.07 | 2021 | |
| Grifols USA, LLC | $16.22 | 2020 | |
| Astellas Pharma US INC | $15.78 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $14.82 | 2019 | |
| Organogenesis INC. | $13.90 | 2021 | |
| Amneal Pharmaceuticals LLC | $12.84 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dean Behner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.